Ligand Pharmaceuticals
LGND
#3746
Rank
โ‚ฌ3.06 B
Marketcap
155,79ย โ‚ฌ
Share price
-0.18%
Change (1 day)
39.39%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.44 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ0.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.10 B37.04%
2023-12-31โ‚ฌ78.06 M-49.3%
2022-12-31โ‚ฌ0.15 B-63.4%
2021-12-31โ‚ฌ0.42 B-20.73%
2020-12-31โ‚ฌ0.53 B-18.3%
2019-12-31โ‚ฌ0.64 B6.18%
2018-12-31โ‚ฌ0.61 B190.86%
2017-12-31โ‚ฌ0.21 B-4.11%
2016-12-31โ‚ฌ0.21 B6.06%
2015-12-31โ‚ฌ0.20 B7.68%
2014-12-31โ‚ฌ0.19 B381.45%
2013-12-31โ‚ฌ39.89 M-32.14%
2012-12-31โ‚ฌ58.79 M-32.07%
2011-12-31โ‚ฌ86.54 M43.17%
2010-12-31โ‚ฌ60.45 M-37.27%
2009-12-31โ‚ฌ96.36 M-25.9%
2008-12-31โ‚ฌ0.13 B31.72%
2007-12-31โ‚ฌ98.73 M-56.38%
2006-12-31โ‚ฌ0.22 B-36.91%
2005-12-31โ‚ฌ0.35 B19.36%
2004-12-31โ‚ฌ0.30 B7.64%
2003-12-31โ‚ฌ0.27 B44.94%
2002-12-31โ‚ฌ0.19 B-2.96%
2001-12-31โ‚ฌ0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ99.81 B 22,244.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ98.09 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ72.90 B 16,219.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ68.30 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ11.83 B 2,549.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ65.86 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ60.68 B 13,483.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ51.98 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚ฌ68.6 M-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA